Dare Bioscience, Inc. — Director's Dealing 2026

Feb 20, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dare Bioscience, Inc. (DARE)
CIK: 0001401914
Period of Report: 2026-02-18

Reporting Person: JOHNSON SABRINA MARTUCCI (Director, Chef Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-18	Series A Convertible Preferred Stock	$2.50	A	10800	Acquired		Common stock (21600)	Direct
2026-02-18	Common Stock Warrant (right to buy)	$4	A	21600	Acquired		Common stock (21600)	Direct

Footnotes

F1: This date is the date on which the reporting person subscribed to purchase the securities. The securities will be issued at a future date when the Issuer accepts the reporting person's subscription.

F2: This security is convertible or exercisable, as applicable, at any time after issuance.

F3: The Series A Convertible Preferred Stock (the Preferred Stock) is perpetual and has no expiration date. The Issuer has the option to redeem the Preferred Stock and the right to require the conversion of the Preferred Stock into shares of the common stock of the Issuer (the Common Stock), in each case, subject to specified conditions.

F4: The reported securities are included within 10,800 Investor Units (the Units) purchased by the reporting person in the Regulation A offering of the Issuer for $5 per Unit. Each Unit consists of one share of Preferred Stock, each of which is initially convertible into two shares of Common Stock, and two warrants, each to purchase one share of Common Stock.

F5: This security expires on the 36-month anniversary of the date of issuance.